Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 12:22 pm Purchase |
2024-09-30 | 13G | RedHill Biopharma Ltd. RDHL |
CVI Investments, Inc. | 672,549,217 4.900% |
672,549,217 (New Position) |
Filing History |
| 2024-08-07 4:43 pm Unchanged |
2024-03-22 | 13D | RedHill Biopharma Ltd. RDHL |
Quintairos, Prieto, Wood & Boyer P.A. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-02 4:10 pm Purchase |
2024-01-25 | 13G | RedHill Biopharma Ltd. RDHL |
Mitchell P. Kopin | 2,000 4.000% |
2,000 (New Position) |
Filing History |
| 2024-02-01 10:22 am Purchase |
2024-01-25 | 13G | RedHill Biopharma Ltd. RDHL |
CVI Investments, Inc. | 1,120,000 5.900% |
1,120,000 (New Position) |
Filing History |
| 2024-01-08 10:23 am Purchase |
2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
Empery Asset Management, LP | 414,607 3.190% |
414,607 (New Position) |
Filing History |
| 2024-01-02 4:26 pm Sale |
2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
SABBY MANAGEMENT LLC | 0 0.000% |
-12,065 (Position Closed) |
Filing History |
| 2023-01-13 08:04 am Purchase |
2022-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
Empery Asset Management, LP | 6,200 6.120% |
6,200 (New Position) |
Filing History |
| 2023-01-04 09:09 am Purchase |
2022-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
SABBY MANAGEMENT LLC | 302 11.000% |
302 (New Position) |
Filing History |
| 2022-03-07 5:25 pm Purchase |
2019-10-17 | 13G | RedHill Biopharma Ltd. RDHL |
Cosmo Pharmaceuticals N.V. | 2,760 13.200% |
2,760 (New Position) |
Filing History |
| 2022-01-27 4:31 pm Sale |
2021-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
Ibex Investors LLC | 52 0.300% |
-859 (-94.24%) |
Filing History |
| 2021-01-15 11:19 am Purchase |
2020-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
Ibex Investors LLC | 911 5.500% |
203 (+28.68%) |
Filing History |